Notably, both activation of JAK/STAT and Notch signaling by IL-6-induce Jagged-1, Hey1, and Hey2, leading to enhanced patient survival, accumulation of CSCs, and drug resistance in cancer [186]. This evidence concerns the gene IL6 and cancer.